Dianthus Therapeutics, Inc. Share Price
NASDAQ: DNTH | Mid CapDianthus Therapeutics, Inc. Stock Performance
Dianthus Therapeutics, Inc. Share Price Today
As of 30 October 2026, Dianthus Therapeutics, Inc.'s share price is $82.70. The stock opened at $83.19, compared to its previous close of $82.12. During today's trading session, Dianthus Therapeutics, Inc.'s share price traded between $81.97 and $83.45, with an average price of $82.71. Over the past 52 weeks, the stock has recorded a high of $117.78 and a low of $32.42. In terms of performance, Dianthus Therapeutics, Inc.'s share price has declined by 5.85% over the last six months and is up 136.56% on a year-on-year basis.
Dianthus Therapeutics, Inc. Share Price Chart
Dianthus Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Dianthus Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Dianthus Therapeutics, Inc.
Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.
Dianthus Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $89.04 | $82.84 | -6.01% |
Sep 2026 | $105.55 | $88.14 | -20.93% |
Aug 2026 | $104.56 | $111.48 | +4.26% |
Jul 2026 | $96.93 | $106.92 | +9.69% |
Jun 2026 | $91.78 | $97.47 | +4.86% |
May 2026 | $89.30 | $92.96 | +5.83% |
Apr 2026 | $86.57 | $87.84 | +4.73% |
Mar 2026 | $53.84 | $83.87 | +52.10% |
Feb 2026 | $52.94 | $55.14 | +3.15% |
Jan 2026 | $41.00 | $53.45 | +29.71% |
Dec 2025 | $43.50 | $41.21 | -6.26% |
Nov 2025 | $34.91 | $43.96 | +25.74% |